Temporal Changes in Transvalvular Pressure Gradients in Balloon‐Expandable and Self‐Expanding Transcatheter Aortic Valves
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.70164 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Surik Sedrakyan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, St Elizabeth's Medical Center, Brighton, Massachusetts, USA. Hauptthemen laut MEDLINE: Aortic Valve Stenosis, Transcatheter Aortic Valve Replacement, Aortic Valve, Heart Valve Prosthesis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Background
Transcatheter aortic valve replacement (TAVR) is evolving as a preferred treatment option for severe aortic stenosis. While self‐expanding valves (SEV) are associated with lower long‐term mean gradients (MG), the timing and mechanisms of gradient changes across valve types remain unclear.
Aims
To evaluate the timing and extent of post‐TAVR mean gradient changes across valve types, sizes, and calcium burden.
Methods
We conducted a retrospective analysis of 288 patients who underwent TAVR. MG was measured using echocardiography immediately post‐deployment (TEE), on Day 1, and at 1–2 months postprocedure (TTE). Early ΔMG was defined as the difference between post‐deployment TEE and Day 1 TTE; intermediate ΔMG as the difference between post‐deployment TEE and 1‐month TTE. Comparisons were performed by valve type, valve size, and calcium score using chi‐square tests for categorical variables and t ‐tests for continuous variables. Logistic regression was used to adjust for potential confounding factors.
Results
Patients receiving balloon‐expandable valves (BEV) had significantly greater early ΔMG (7.65 ± 0.75 mmHg) compared to SEV (2.55 ± 0.65 mmHg; p < 0.0001). Intermediate ΔMG was also higher in BEV (8.0 ± 0.7 vs. 2.2 ± 1.1 mmHg; p < 0.0001). Smaller valve sizes, particularly the 23 mm BEV, were associated with the largest gradient increases. Calcium score had a minimal impact on early MG and no effect on intermediate MG.
Conclusions
Hemodynamic changes begin within the first 24 h after TAVR, with BEV showing more pronounced early and intermediate increases in MG compared to SEV. These findings suggest that valve type and size are major drivers of post‐TAVR gradient behavior, whereas calcium burden plays a limited role.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, St Elizabeth's Medical Center, Brighton, Massachusetts, USA.
- Cardiovascular Division, St. Elizabeth's Medical Center, Brighton, Massachusetts, USA.
- Department of Cardivascular Surgery, St Elizabeth's Medical Center, Brighton, Massachusetts, USA.
ORCID-Profile: Surik Sedrakyan
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Sedrakyan, S., Nikolaeva, M., Bhat, T., Khan, F., Agnihotri, A., Nicholson, N., Watrous, J., Maysky, M., & Carrozza, J. P. (2025). Temporal Changes in Transvalvular Pressure Gradients in Balloon‐Expandable and Self‐Expanding Transcatheter Aortic Valves. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70164
Vancouver
Sedrakyan S, Nikolaeva M, Bhat T, Khan F, Agnihotri A, Nicholson N, et al. Temporal Changes in Transvalvular Pressure Gradients in Balloon‐Expandable and Self‐Expanding Transcatheter Aortic Valves. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.70164
BibTeX
@article{Sedrakyan2025,
author = {Sedrakyan, Surik and Nikolaeva, Mariia and Bhat, Tariq and Khan, Faisal and Agnihotri, Arvind and Nicholson, Nancy and Watrous, Jeanne and Maysky, Michael and Carrozza, Joseph P},
title = {Temporal Changes in Transvalvular Pressure Gradients in Balloon‐Expandable and Self‐Expanding Transcatheter Aortic Valves},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.70164}
}
EUVIMED